- Investing Ideas
- /
- Global Biotech Stocks
Global Biotech Stocks
Results
1374
Even though biotechnology stocks can be very risky, they can also offer some of the biggest rewards with huge profits on offer when you find the right one. The companies below all have reasonable balance sheets and value, giving the best chance of finding a gem.
1374 companies
Formycon
Market Cap: €390.4m
A biotechnology company, develops biosimilar drugs in Germany and Switzerland.
FYB
€22.10
7D
-5.4%
1Y
-58.4%
Blau Farmacêutica
Market Cap: R$2.4b
A pharmaceutical company provides high-complpexity drugs in Brazil, Argentina, Chile, Colombia, Uruguay, Ecuador, Peru, and the United States.
BLAU3
R$13.65
7D
-3.9%
1Y
-0.8%
Guangdong VTR Bio-Tech
Market Cap: CN¥3.2b
Researches, develops, produces, sells, and services biological enzyme preparations, biosynthetics, and nutrition and health products in China.
300381
CN¥6.74
7D
-2.9%
1Y
7.0%
Honz Pharmaceutical
Market Cap: CN¥3.2b
Engages in the research and development, manufacturing, and sales of pediatric medicines in China.
300086
CN¥7.08
7D
4.3%
1Y
63.9%
Hunan Hansen Pharmaceutical
Market Cap: CN¥3.2b
Produces and sells traditional Chinese preparations in China and internationally.
002412
CN¥6.39
7D
-1.4%
1Y
12.9%
ASKA Pharmaceutical HoldingsLtd
Market Cap: JP¥67.2b
Through its subsidiaries, engages in the pharmaceutical, animal health, and hormone testing businesses in Japan.
4886
JP¥2,369.00
7D
-0.7%
1Y
5.1%
Beximco Pharmaceuticals
Market Cap: ৳54.4b
Manufactures and markets generic pharmaceutical formulations and active pharmaceutical ingredients in Bangladesh.
BXPHARMA
৳121.90
7D
3.2%
1Y
71.0%
Guizhou Yibai Pharmaceutical
Market Cap: CN¥3.2b
Researches, develops, produces, and sells pharmaceutical products in China.
600594
CN¥4.06
7D
-3.8%
1Y
13.7%
Shanghai Kehua Bio-EngineeringLtd
Market Cap: CN¥3.2b
Researches and develops, produces, and sells in vitro diagnostic reagents, medical testing equipment and other products in China and internationally.
002022
CN¥6.34
7D
-2.8%
1Y
2.8%
Abbott Laboratories (Pakistan)
Market Cap: PK₨124.5b
Manufactures, imports, and markets generic pharmaceutical, nutritional, diagnostic, diabetes care, molecular devices, hospital, and consumer products in Pakistan, Afghanistan, Sri Lanka, Bangladesh, and Switzerland.
ABOT
PK₨1,271.91
7D
9.2%
1Y
64.0%
Shaanxi Panlong Pharmaceutical Group Limited By Share
Market Cap: CN¥3.1b
Researches and develops, produces, and sells Chinese patent medicines in China.
002864
CN¥29.30
7D
-2.7%
1Y
13.1%
Knight Therapeutics
Market Cap: CA$605.9m
Focuses on acquiring, in-licensing, out-licensing, marketing, and commercializing prescription pharmaceutical products in Canada and Latin America.
GUD
CA$5.93
7D
-4.8%
1Y
0.7%
Cytek Biosciences
Market Cap: US$431.3m
A cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications.
CTKB
US$3.40
7D
-10.1%
1Y
-36.9%
RPG Life Sciences
Market Cap: ₹38.1b
An integrated pharmaceutical company, develops, manufactures, and markets branded formulations, generic, and synthetic active pharmaceutical ingredients (APIs) in India and internationally.
RPGLIFE
₹2,305.20
7D
-5.6%
1Y
0.7%
Anhui Fengyuan Pharmaceutical
Market Cap: CN¥3.0b
Researches and develops, produces, and sells biopharmaceuticals, chemical pharmaceuticals, Chinese patent medicines, Chinese herbal decoction pieces, and APIs primarily in China.
000153
CN¥6.50
7D
-1.1%
1Y
15.0%
Anhui Sunhere Pharmaceutical ExcipientsLtd
Market Cap: CN¥3.0b
Anhui Sunhere Pharmaceutical Excipients Co.,Ltd.
300452
CN¥12.90
7D
-2.1%
1Y
9.5%
BioNote
Market Cap: ₩591.9b
Manufactures and sells in-vitro diagnostic animal medicines in South Korea.
A377740
₩5,840.00
7D
-6.0%
1Y
28.5%
AprilBioLtd
Market Cap: ₩590.1b
AprilBio Co., Ltd. develops long-acting type biobetter and antibody biologics.
A397030
₩26,150.00
7D
-7.1%
1Y
16.0%
Verano Holdings
Market Cap: CA$578.9m
Operates as a vertically integrated multi-state cannabis operator in the United States.
VRNO
CA$1.56
7D
-5.5%
1Y
-65.0%
PharmaSGP Holding
Market Cap: €354.6m
Manufactures and sells over-the-counter drugs and other healthcare products in Germany.
PSG
€30.80
7D
4.1%
1Y
n/a
Orchid Pharma
Market Cap: ₹36.6b
A pharmaceutical company, engages in the development, manufacture, and marketing of active pharmaceutical ingredients, bulk actives, finished dosage formulations, and nutraceuticals in India.
ORCHPHARMA
₹721.45
7D
-8.5%
1Y
-49.4%
I-Mab
Market Cap: US$405.2m
A biotech company, focuses on the development of immuno-oncology agents for the treatment of cancer in the United States.
IMAB
US$3.48
7D
-8.2%
1Y
202.6%
PureTech Health
Market Cap: UK£302.1m
Engages in the development and commercialization of biotechnology and pharmaceutical solutions in the United States.
PRTC
UK£1.25
7D
4.0%
1Y
-19.0%
Tanvex BioPharma
Market Cap: NT$12.4b
A biopharmaceutical company, researches, develops, manufactures, and sells biosimilar products in Taiwan and the United States.
6541
NT$51.80
7D
4.1%
1Y
-25.5%
Autolus Therapeutics
Market Cap: US$399.2m
A clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer and autoimmune diseases in United Kingdom and internationally.
AUTL
US$1.56
7D
16.4%
1Y
-57.0%
Assembly Biosciences
Market Cap: US$397.2m
A biotechnology company, develops therapeutic candidates for the treatment of viral diseases worldwide.
ASMB
US$24.67
7D
0.9%
1Y
56.2%
Shandong Sito Bio-technology
Market Cap: CN¥2.8b
Researches, develops, and produces steroid biomedicine intermediates.
300583
CN¥14.86
7D
-3.9%
1Y
-9.7%
4D Molecular Therapeutics
Market Cap: US$393.2m
A late-stage biotechnology company, engages in the development of adeno-associated virus vectors from its proprietary synthetic vector discovery platform, Therapeutic Vector Evolution in the Netherlands and the United States.
FDMT
US$8.39
7D
27.1%
1Y
-22.5%
Cutia Therapeutics
Market Cap: HK$3.0b
An investment holding company, engages in the research, development, manufacture, and commercialization of scalp diseases and care products, and skin care products in the People’s Republic of China and Hong Kong.
2487
HK$8.73
7D
-7.7%
1Y
-46.1%
Kamada
Market Cap: ₪1.3b
Manufactures and sells plasma-derived protein therapeutics.
KMDA
₪22.40
7D
-3.3%
1Y
12.2%
Antibiotice
Market Cap: RON 1.7b
Produces and sells medicinal products in Romania and internationally.
ATB
RON 2.47
7D
-2.0%
1Y
-26.5%
Mabpharm
Market Cap: HK$3.0b
A biopharmaceutical company, engages in research, development, production, and commercialization of drugs and biosimilar for cancers and autoimmune diseases in the People’s Republic of China.
2181
HK$0.72
7D
-7.7%
1Y
118.2%
Hanshang Group
Market Cap: CN¥2.7b
Primarily engages in the retail business.
600774
CN¥9.39
7D
-2.2%
1Y
25.9%
Unichem Laboratories
Market Cap: ₹33.7b
A pharmaceutical company, manufactures and sells pharmaceutical products in India, the United States, and internationally.
506690
₹478.70
7D
-4.8%
1Y
-25.9%
Jacobson Pharma
Market Cap: HK$2.9b
Through its subsidiaries, engages in the research, development, production, sale, and distribution of medicine and drugs in Hong Kong, Mainland China, Macau, Singapore, and internationally.
2633
HK$1.47
7D
0.7%
1Y
145.0%
Essex Bio-Technology
Market Cap: HK$2.9b
An investment holding company, develops, manufactures, and sells biologic drugs in China, Hong Kong, and internationally.
1061
HK$5.17
7D
-1.9%
1Y
111.0%